Safe nanoparticles: are we there yet?

W Najahi-Missaoui, RD Arnold… - International journal of …, 2020 - mdpi.com
The field of nanotechnology has grown over the last two decades and made the transition
from the benchtop to applied technologies. Nanoscale-sized particles, or nanoparticles …

Toxicity of metal-based nanoparticles: Challenges in the nano era

N Zhang, G Xiong, Z Liu - Frontiers in Bioengineering and …, 2022 - frontiersin.org
With the rapid progress of nanotechnology, various nanoparticles (NPs) have been
applicated in our daily life. In the field of nanotechnology, metal-based NPs are an important …

Nanodelivery of natural antioxidants: an anti-aging perspective

A Vaiserman, A Koliada, A Zayachkivska… - … in bioengineering and …, 2020 - frontiersin.org
The aging process is known to be associated with heightened oxidative stress and related
systemic inflammation. Therefore, antioxidant supplementation is regarded as a promising …

A Safe‐by‐Design strategy towards safer nanomaterials in nanomedicines

L Yan, F Zhao, J Wang, Y Zu, Z Gu… - Advanced Materials, 2019 - Wiley Online Library
The marriage of nanotechnology and medicine offers new opportunities to fight against
human diseases. Benefiting from their unique optical, thermal, magnetic, or redox properties …

Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy

Y Lu, D Zhu, Q Le, Y Wang, W Wang - Nanoscale, 2022 - pubs.rsc.org
Ruthenium complex is an important compound group for antitumor drug research and
development. NAMI-A, KP1019, TLD1433 and other ruthenium complexes have entered …

Nanoparticles in medicine: current status in cancer treatment

K Pavelić, SK Pavelić, A Bulog, A Agaj… - International journal of …, 2023 - mdpi.com
Cancer is still a leading cause of deaths worldwide, especially due to those cases
diagnosed at late stages with metastases that are still considered untreatable and are …

Recent development of nanomaterials for transdermal drug delivery

MY Leong, YL Kong, K Burgess, WF Wong, G Sethi… - Biomedicines, 2023 - mdpi.com
Nano-engineered medical products first appeared in the last decade. The current research
in this area focuses on developing safe drugs with minimal adverse effects associated with …

A Sub-6 nm MnFe2O4-dichloroacetic acid nanocomposite modulates tumor metabolism and catabolism for reversing tumor immunosuppressive microenvironment …

Z Dai, Q Wang, J Tang, R Qu, M Wu, H Li, Y Yang… - Biomaterials, 2022 - Elsevier
Adenosine and lactate accumulated in tumor microenvironment are two major causes of
immunosuppression, their concurrent downregulation holds promise in effective cancer …

“Plug and play” functionalized erythrocyte nanoplatform for target atherosclerosis management

Y Zhong, X Qin, Y Wang, K Qu, L Luo… - … Applied Materials & …, 2021 - ACS Publications
For atherosclerosis (AS) management, a therapeutic drug intervention is the most widely
used strategy. However, there are some problems such as low location specificity, high …

Compendium of naringenin: Potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile

S Singh, A Sharma, V Monga… - Critical Reviews in Food …, 2023 - Taylor & Francis
Naringenin is flavorless, water insoluble active principle belonging to flavanone subclass. It
exhibits a diverse pharmacological profile as well as divine nutraceutical values. Although …